Skip to main content
Top
Published in: BMC Health Services Research 1/2007

Open Access 01-12-2007 | Research article

Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study

Authors: Jean-Philippe Nordmann, Philippe Denis, Marc Vigneux, Elyse Trudeau, Isabelle Guillemin, Gilles Berdeaux

Published in: BMC Health Services Research | Issue 1/2007

Login to get access

Abstract

Background

Compliance is a major issue in glaucoma care. It is usually poor in glaucomatous patients, and may ultimately result in an acceleration of the disease progression and a risk of blindness. Reasons for this poor compliance are complex and multifactorial, amongst which patient satisfaction can be counted. The objective of this study was to develop a questionnaire to assess patient satisfaction and compliance with eye-drop treatment.

Methods

A qualitative study was carried out to develop the questionnaire. An interview guide was developed based on a literature review. Structured interviews of fifteen French and English patients with primary open-angle glaucoma or intraocular hypertension were conducted by trained interviewers of the native language of the interviewees. General concepts and subconcepts were identified from the transcripts. The questionnaire was developed using the patient verbatim, and submitted to six patients (French and English) for cognitive debriefing. Following patients' comments, items were modified and restructured, and a pilot questionnaire was designed.

Results

Analysis of data from the interviews with patients and clinicians resulted in the elicitation of concepts related to patient satisfaction and compliance with glaucomatous treatment. These were further refined and used to generate a test questionnaire, which consisted of 46 items grouped into 6 domains: patient characteristics, treatment characteristics, patient-clinician relationship, patient experience with the disease and the treatment, interaction between the patient and the treatment, and patient knowledge of the disease and the treatment.

Conclusion

The Eye-Drop Satisfaction Questionnaire (EDSQ) conceptual framework and items were developed simultaneously in French and in English. This questionnaire could be used to evaluate patient satisfaction and compliance with eye-drop treatment and would facilitate the identification of patients at risk of being non-compliant prior to clinical trials or innovative device tests. A psychometric study is under way to validate the questionnaire.
Appendix
Available only for authorised users
Literature
1.
go back to reference Berdeaux G, Brézin A, Fagnani F, Lafuma A, Mesbah M: Self-reported visual impairment and mortality: a French nationwide perspective. Ophthalmic Epidemiol. 2007, 14: 80-87. 10.1080/09286580600899691.CrossRef Berdeaux G, Brézin A, Fagnani F, Lafuma A, Mesbah M: Self-reported visual impairment and mortality: a French nationwide perspective. Ophthalmic Epidemiol. 2007, 14: 80-87. 10.1080/09286580600899691.CrossRef
2.
go back to reference Goldstein H: Magnitude and causes of blindness: Sources and limitations of data. Clinical ophthalmology. Volume 2. Edited by: Freemann JS. 1990, Philadelphia, USA: Lippincott Company, 5: 1-10. Goldstein H: Magnitude and causes of blindness: Sources and limitations of data. Clinical ophthalmology. Volume 2. Edited by: Freemann JS. 1990, Philadelphia, USA: Lippincott Company, 5: 1-10.
3.
go back to reference Brézin AP, Lafuma A, Fagnani F, Mesbah M, Berdeaux G: Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol. 2005, 123: 1117-1124. 10.1001/archopht.123.8.1117.CrossRef Brézin AP, Lafuma A, Fagnani F, Mesbah M, Berdeaux G: Prevalence and burden of self-reported blindness, low vision, and visual impairment in the French community: a nationwide survey. Arch Ophthalmol. 2005, 123: 1117-1124. 10.1001/archopht.123.8.1117.CrossRef
4.
go back to reference Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J, Eye Diseases Prevalence Research Group: Prevalence of Open-Angle Glaucoma among adults in the United States. Arch Ophthalmol. 2004, 122: 532-538. 10.1001/archopht.122.7.1019.CrossRef Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S, Leske MC, Mitchell P, Congdon N, Kempen J, Eye Diseases Prevalence Research Group: Prevalence of Open-Angle Glaucoma among adults in the United States. Arch Ophthalmol. 2004, 122: 532-538. 10.1001/archopht.122.7.1019.CrossRef
5.
go back to reference Tuck MW, Crick RP: The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998, 5: 173-183. 10.1076/opep.5.4.173.4192.CrossRef Tuck MW, Crick RP: The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998, 5: 173-183. 10.1076/opep.5.4.173.4192.CrossRef
6.
go back to reference Schappert SM: Office visits for glaucoma: United States, 1991–1992. Adv Data. 1995, 1-14. 262 Schappert SM: Office visits for glaucoma: United States, 1991–1992. Adv Data. 1995, 1-14. 262
8.
go back to reference Lafuma A, Brézin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V, Berdeaux G: Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the United Kingdom. Pharmacoeconomics. 2006, 24: 193-205. 10.2165/00019053-200624020-00007.CrossRef Lafuma A, Brézin A, Lopatriello S, Hieke K, Hutchinson J, Mimaud V, Berdeaux G: Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the United Kingdom. Pharmacoeconomics. 2006, 24: 193-205. 10.2165/00019053-200624020-00007.CrossRef
9.
go back to reference Odberg T, Jakobsen JE, Hultgren SJ, Halseide R: The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001, 79: 121-124. 10.1034/j.1600-0420.2001.079002121.x.CrossRef Odberg T, Jakobsen JE, Hultgren SJ, Halseide R: The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmol Scand. 2001, 79: 121-124. 10.1034/j.1600-0420.2001.079002121.x.CrossRef
10.
go back to reference Spaeth G, Walt J, Keener J: Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006, 141: 3-14. 10.1016/j.ajo.2005.07.075.CrossRef Spaeth G, Walt J, Keener J: Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006, 141: 3-14. 10.1016/j.ajo.2005.07.075.CrossRef
11.
go back to reference Brézin A, Lafuma A, Fagnani F, Mesbah M, Berdeaux G: Blindness, low vision and other handicaps as risk factors attached to institutional residence. Br J Ophthalmol. 2004, 88: 1330-1337. 10.1136/bjo.2003.039180.CrossRef Brézin A, Lafuma A, Fagnani F, Mesbah M, Berdeaux G: Blindness, low vision and other handicaps as risk factors attached to institutional residence. Br J Ophthalmol. 2004, 88: 1330-1337. 10.1136/bjo.2003.039180.CrossRef
12.
go back to reference Lafuma A, Brézin A, Fagnani F, Mimaud V, Mesbah M, Berdeaux G: Nonmedical economic consequences attributable to visual impairment: A nation-wide approach in France. Eur J Health Econ. 2006, 7: 158-164. 10.1007/s10198-006-0346-1.CrossRef Lafuma A, Brézin A, Fagnani F, Mimaud V, Mesbah M, Berdeaux G: Nonmedical economic consequences attributable to visual impairment: A nation-wide approach in France. Eur J Health Econ. 2006, 7: 158-164. 10.1007/s10198-006-0346-1.CrossRef
13.
go back to reference Nordmann JP, Viala M, Sullivan K, Arnoult B, Berdeaux G: Psychometric validation of the National Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics. 2004, 22: 197-206. 10.2165/00019053-200422030-00005.CrossRef Nordmann JP, Viala M, Sullivan K, Arnoult B, Berdeaux G: Psychometric validation of the National Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics. 2004, 22: 197-206. 10.2165/00019053-200422030-00005.CrossRef
14.
go back to reference Armaly MF: Ocular pressure and visual fields. A ten-year follow-up study. Arch Ophthalmol. 1969, 81: 25-40.CrossRef Armaly MF: Ocular pressure and visual fields. A ten-year follow-up study. Arch Ophthalmol. 1969, 81: 25-40.CrossRef
15.
go back to reference Kitazawa Y, Horie T, Aoki S, Suzuki M, Nishioka K: Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol. 1977, 95: 1180-1184.CrossRef Kitazawa Y, Horie T, Aoki S, Suzuki M, Nishioka K: Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol. 1977, 95: 1180-1184.CrossRef
16.
go back to reference Collaborative Normal-Tension Glaucoma Study Group: Comparaison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998, 126: 487-497. 10.1016/S0002-9394(98)00223-2.CrossRef Collaborative Normal-Tension Glaucoma Study Group: Comparaison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998, 126: 487-497. 10.1016/S0002-9394(98)00223-2.CrossRef
17.
go back to reference Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group: Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002, 120: 1268-1279.CrossRef Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group: Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002, 120: 1268-1279.CrossRef
18.
go back to reference Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO: The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002, 120: 701-713.CrossRef Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO: The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002, 120: 701-713.CrossRef
19.
go back to reference The AGIS investigators: The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intra-ocular pressure and visual field deterioration. Am J Ophthalmol. 2000, 130: 429-440. 10.1016/S0002-9394(00)00538-9.CrossRef The AGIS investigators: The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intra-ocular pressure and visual field deterioration. Am J Ophthalmol. 2000, 130: 429-440. 10.1016/S0002-9394(00)00538-9.CrossRef
20.
go back to reference Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM: Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998, 105: 2105-2111. 10.1016/S0161-6420(98)91134-4.CrossRef Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM: Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998, 105: 2105-2111. 10.1016/S0161-6420(98)91134-4.CrossRef
21.
go back to reference Stewart WC, Konstas AG, Pfeiffer N: Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther. 2004, 20: 461-469. 10.1089/jop.2004.20.461.CrossRef Stewart WC, Konstas AG, Pfeiffer N: Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther. 2004, 20: 461-469. 10.1089/jop.2004.20.461.CrossRef
23.
go back to reference Denis P, Lafuma A, Berdeaux G: Medical outcomes of glaucoma therapy from a nationwide representative survey. Clin Drug Investig. 2004, 24: 343-352. 10.2165/00044011-200424060-00004.CrossRef Denis P, Lafuma A, Berdeaux G: Medical outcomes of glaucoma therapy from a nationwide representative survey. Clin Drug Investig. 2004, 24: 343-352. 10.2165/00044011-200424060-00004.CrossRef
24.
go back to reference Nordmann JP, Auzanneau N, Ricard S, Berdeaux G: Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003, 1: 1-9. 10.1186/1477-7525-1-75.CrossRef Nordmann JP, Auzanneau N, Ricard S, Berdeaux G: Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003, 1: 1-9. 10.1186/1477-7525-1-75.CrossRef
25.
go back to reference Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B: Patient-reported behaviour and problems in using glaucoma medications. Ophthalmology. 2006, 113: 431-436. 10.1016/j.ophtha.2005.10.034.CrossRef Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B: Patient-reported behaviour and problems in using glaucoma medications. Ophthalmology. 2006, 113: 431-436. 10.1016/j.ophtha.2005.10.034.CrossRef
26.
go back to reference Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW: Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003, 12: 393-398. 10.1097/00061198-200310000-00001.CrossRef Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW: Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003, 12: 393-398. 10.1097/00061198-200310000-00001.CrossRef
27.
go back to reference Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S: The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes study. J Behav Med. 1994, 17: 347-360. 10.1007/BF01858007.CrossRef Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S: The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes study. J Behav Med. 1994, 17: 347-360. 10.1007/BF01858007.CrossRef
28.
go back to reference Woodside AG, Frey LL, Day RT: Linking service quality, customer satisfaction, and behavioral intention. J Health Care Mark. 1989, 9: 5-17.PubMed Woodside AG, Frey LL, Day RT: Linking service quality, customer satisfaction, and behavioral intention. J Health Care Mark. 1989, 9: 5-17.PubMed
29.
go back to reference Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC: The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye. 2006, 20: 583-590. 10.1038/sj.eye.6701932.CrossRef Day DG, Sharpe ED, Atkinson MJ, Stewart JA, Stewart WC: The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye. 2006, 20: 583-590. 10.1038/sj.eye.6701932.CrossRef
30.
go back to reference Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy D: Patient-Reported Outcomes to support medical product labelling claims. Unpublished data. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy D: Patient-Reported Outcomes to support medical product labelling claims. Unpublished data.
31.
go back to reference Charmaz K: The Grounded Theory. Rethinking methods in psychology. Edited by: Smith JA, Harré R, Van Langenhove L. 1995, London, Sage, 27-49.CrossRef Charmaz K: The Grounded Theory. Rethinking methods in psychology. Edited by: Smith JA, Harré R, Van Langenhove L. 1995, London, Sage, 27-49.CrossRef
32.
go back to reference Kubin M, Trudeau E, Gondek K, Seignobos E, Fugl-Meyer AR: Early Conceptual and linguistic development of a patient and partner Treatment Satisfaction Scale (TSS) for erectile dysfunction. Eur Urol. 2004, 46: 768-775. 10.1016/j.eururo.2004.08.001.CrossRef Kubin M, Trudeau E, Gondek K, Seignobos E, Fugl-Meyer AR: Early Conceptual and linguistic development of a patient and partner Treatment Satisfaction Scale (TSS) for erectile dysfunction. Eur Urol. 2004, 46: 768-775. 10.1016/j.eururo.2004.08.001.CrossRef
33.
go back to reference Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004, 2: 12-10.1186/1477-7525-2-12.CrossRef Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004, 2: 12-10.1186/1477-7525-2-12.CrossRef
34.
go back to reference Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E, Lohs J: A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP). Health Qual Life Outcomes. 2003, 1 (1): 67-. 10.1186/1477-7525-1-67.CrossRef Atkinson MJ, Stewart WC, Fain JM, Stewart JA, Dhawan R, Mozaffari E, Lohs J: A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP). Health Qual Life Outcomes. 2003, 1 (1): 67-. 10.1186/1477-7525-1-67.CrossRef
35.
go back to reference Morse JM: The significance of saturation. Qual Health Res. 1995, 5: 145-147. Morse JM: The significance of saturation. Qual Health Res. 1995, 5: 145-147.
36.
go back to reference Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006, 18: 59-82. 10.1177/1525822X05279903.CrossRef Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006, 18: 59-82. 10.1177/1525822X05279903.CrossRef
Metadata
Title
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study
Authors
Jean-Philippe Nordmann
Philippe Denis
Marc Vigneux
Elyse Trudeau
Isabelle Guillemin
Gilles Berdeaux
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2007
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-7-124

Other articles of this Issue 1/2007

BMC Health Services Research 1/2007 Go to the issue